| Nov 7 |
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Nov 7 |
Insulet (PODD) Q3 Earnings and Revenues Top Estimates
|
| Nov 7 |
Insulet: Q3 Earnings Snapshot
|
| Nov 7 |
Insulet Non-GAAP EPS of $0.90 beats by $0.14, revenue of $543.9M beats by $24.62M
|
| Nov 7 |
Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)
|
| Nov 6 |
Insulet Q3 2024 Earnings Preview
|
| Nov 6 |
Tandem, Insulet draw bullish views at Bernstein ahead of earnings
|
| Nov 4 |
Insulet Stock Gains From Expansion Strategies, Innovation
|
| Nov 4 |
Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics
|
| Nov 1 |
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
|
